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Abstract: Biofilm bacteria are more resistant to antibiotics than planktonic cells. Propolis possesses
antimicrobial activity. Generally, nanoparticles containing heavy metals possess antimicrobial and
antibiofilm properties. In this study, the ability of adherence of Methicillin Resistant Strains of
Staphylococcus aureus (MRSA) to catheters treated with magnetite nanoparticles (MNPs), produced
by three methods and functionalized with oleic acid and a hydro-alcoholic extract of propolis
from Morocco, was evaluated. The chemical composition of propolis was established by gas
chromatography mass spectrometry (GC-MS), and the fabricated nanostructures characterized by
X-ray diffraction (XRD), transmission electron microscopy (TEM), Mossbauer spectroscopy and
Fourrier transform infrared spectroscopy (FTIR). The capacity for impairing biofilm formation was
dependent on the strain, as well as on the mode of production of MNPs. The co-precipitation method
of MNPs fabrication using Fe3+ and Na2SO3 solution and functionalized with oleic acid and propolis
was the most effective in the impairment of adherence of all MRSA strains to catheters (p < 0.001).
The adherence of the strain MRSA16 was also significantly lower (p < 0.001) when the catheters were
treated with the hybrid MNPs with oleic acid produced by a hydrothermal method. The anti-MRSA
observed can be attributed to the presence of benzyl caffeate, pinocembrin, galangin, and isocupressic
acid in propolis extract, along with MNPs. However, for MRSA16, the impairment of its adherence
on catheters may only be attributed to the hybrid MNPs with oleic acid, since very small amount,
if any at all of propolis compounds were added to the MNPs.
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1. Introduction
Propolis is a natural resinous substance collected by honeybees from parts of plants, buds, and
exudates, mixed with bees wax and salivary enzymes. Propolis is mainly constituted by resin (50%),
wax (30%), essential oils (10%), pollen (5%), and other substances (5%), such as debris, minerals
and organic compounds, despite the chemical variability that can be found. Such differences
can be attributed to the different plants from where bees can collect the materials, as well as the
different harvesting seasons of propolis. Polyphenols, terpenoids including steroids, naphthalene
and stilbene derivatives, and fatty acids are some examples of organic compounds that can be
found in propolis [1,2]. Different biological properties have been attributed to propolis, such as
antimicrobial, anti-inflammatory, antioxidant, antidiabetic, spasmolytic, anaesthetic, anticancer,
and immunomodulatory effects [2,3].
Staphylococcus aureus is a Gram-positive bacterium that mainly colonizes the nares and
is considered a human pathogen that shows increasing incidence in patients with prolonged
hospitalization, submitted to intravenous drugs or under treatment with enteral feedings or dialysis,
in postoperative surgical wounds in decubitus ulcers or in indwelling catheters [4–6]. Its incidence
is increasing also in the community [7]. Over time, Staphylococcus aureus has developed resistance to
several antibiotics and, presently, methicillin resistant strains (MRSA) are causing serious infections
in hospitals or even in the community [8,9]. For these reasons, alternative approaches are required
to fight this bacterial pathogen, and one of them is the use of natural products. Propolis comes as
a natural candidate due to its multidirectional mechanism of action on bacterial cells, which renders
the development of resistance unlikely [10]. The utilization of propolis extracts has already been
assayed as anti-MRSA agents, as is shown in Table 1, which compiles the results of several authors
who observed anti-MRSA activity in propolis of diverse origins.
Biofilm bacteria (adherent bacterial cells) are more resistant to antibiotics, cleaning and eradication
than planktonic cells (cells in suspension). The percentage of infections associated with biofilm
formation in medical devices is more than 25%. These infections cause great mortality and morbidity
rates in patients with indwelling or implanted devices, with the consequent increasing of costs due to
the long term treatments [11].
Different types of nanoparticles have been reported as possessing antimicrobial and antibiofilm
properties, particularly those containing heavy metals [12]. Iron oxide magnetic nanoparticles were
approved by FDA for biomedical uses, because they occur naturally in liver, spleen and human heart,
consequently, they will be non-toxic and biocompatible at physiological concentrations. In addition,
the production of these nanoparticles is not difficult and they are chemically stable under physiological
conditions. They are also easily functionalized. Functionalized iron oxide magnetic nanoparticles, such as
magnetite nanoparticles (MNPs) have been evaluated for inhibiting microbial growth and biofilm
formation of yeasts (Candida albicans, C. tropicalis, C. krusei, C. glabrata, and Saccharomyces cerevisiae), and
bacteria (Escherichia coli, Staphylococcus aureus, Pseudomonas aeruginosa, and Enterococcus faecalis) [13].
The majority of the methods used for synthesizing stable, biocompatible and monodispersed
MNPs include co-precipitation, thermal decomposition, hydrothermal synthesis, microemulsion,
and sonochemical synthesis. However, other methods have been developed and reported:
electrochemical synthesis, laser pyrolysis techniques, and microorganism or bacterial synthesis [14].
In order to prevent that MNPs form aggregates, and for raising its biocompatibility, stability and
biological application, such NPs may be functionalized with some biomolecules [14]. Oleic acid
has been used alone or along with natural products for preventing biofilm formation of pathogenic
microorganisms (C. albicans, C. tropicalis, S. aureus, and E. coli) or for promoting its disruption [12,15,16].
The main goal of the present work was to evaluate the ability of a hybrid nanosystem constituted
by magnetite nanoparticles, produced by three methods based on two methods (co-precipitation
and hydrothermal synthesis) and functionalized with oleic acid and a hydro-alcoholic extract of
propolis from Morocco to prevent the adherence of MRSA strains on catheters, and therefore impair
the formation of biofilm.
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Table 1. Utilization of propolis extracts as anti-Methicillin Resistant Strains of Staphylococcus aureus (anti-MRSA) agents.
Sample Sample Extraction/Compounds Strains MIC * (mg/mL); MBC ** (mg/mL) Major Compounds Ref.
Twenty-four batches of
propolis collected over two
years (2010 and 2011) from
different places in France
1. Methanol (MeOH)
Six human pathogenic bacterial
strains collected by the Laboratory
of Bacteriology at the University
Hospital, Center of Angers, France)
0.090–>0.100; - Pinobanksin-3-acetate, pinocembrin, chrysin, galangin,prenyl caffeate [17]
2. Dichloromethane (DCM) The same reported above 0.057–0.097; - The same reported above
3. Mixture of DCM, MeOH, H2O (31/19/4) The same reported above
0.030;
> 0.100 The same reported above
Pinobanksin-3-acetate MRSA (0706C0025)MRSA (0702E0196)
>0.100; -
>0.100; -
Pinocembrin MRSA (0706C0025)MRSA (0702E0196)
>0.100; -
>0.100; -
Chrysin MRSA (0706C0025)MRSA (0702E0196)
>0.100; -
>0.100; -
Galangin MRSA (0706C0025)MRSA (0702E0196)
>0.100; -
>0.100; -
Prenyl caffeate MRSA (0706C0025)MRSA (0702E0196)
0.070; -
0.070; -
Propolis, collected at
Moravia, Czech Republic
Special propolis extract GH2002 (see the
reference for the extraction method) Ten strains
0.13–0.25;
0.5–1 - [18]
Propolis samples from
an apiary in Kamianna
near Nowy Sa˛cz in
Southern Poland
Hydro-alcoholic (70%) extract of propolis
Five strains from blood
clinical origin
MRSA ATCC 43300
0.39–0.78;
0.78–3.13;
0.78; 3.13
Pinocembrin, kaempferol, galangin, chrysin, apigenin,
quercetin, gallic acid, ferullic acid, caffeic acid, caffeic acid
phenethyl ester, p-coumaric acid and cinnamic acid
[10]
The crude propolis and
their respective ethanol
extracts were sourced from
the city of União da Vitória,
-State of Paraná, Brazil,
provided by Novo Mel®
Ethanol extracts
Strains (clinical isolate) were
obtained from the Bacterial Library
of the Microbiology Laboratory,
Department of Pathology, Santa
Casa de São Paulo, -School of
Medical Sciences
1.42
3-[4-Hydroxy-3-(oxobutyl)-phenylacrylic acid;
3-prenyl-3(E)-(4-hydroxy-3-methyl-2-butenol)-5-prenylcinnamic
acid; 3-prenyl-4-(2-methylpropionyloxi)cinnamic acid;
3-prenyl-4-dihydrocynamoiloxi-cinnamic acid;
dihydrokaemferide; 3-prenyl-4-hydroxycinnamic acid, caffeic
acid; caffeoylquinic acid 1; caffeoylquinic acid 2; caffeoylquinic
acid 3; caffeoylquinic acid 4; caffeoylquinic acid 5; cinnamic
acid; p-coumaric acid; kaempferide; kaempferol; betuletol;
2,2-dimethyl-6-carboxyethenyl-2H-1-benzopirane;
2,2-dimethyl-8-prenyl-2H-1-benzopirano-6-propenoic acid;
(E)-3-{4-hydroxy-3-[(E)-4-(2,3)-dihydrocynamoiloxi-3-methyl-
2-butenyl]-5-renylphenyl-2-propenoic acid;
3,4-dihydroxy-5-prenyl-cinnamic acid;
3,5-diprenyl-4-hydroxy-cinnamic acid
[19]
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Table 1. Cont.
Sample Sample Extraction/Compounds Strains MIC * (mg/mL); MBC ** (mg/mL) Major Compounds Ref.
Two Jordanian propolis
samples from two locations:
University of Jordan
(Type I), and Al-Hashmeah
(Type II)
Type I crude aqueous methanol extracts
Type II crude aqueous methanol extracts
Pinobanksin-3-O-acetate Pinocembrin
MRSA isolated from hospitalized
patients at the Jordan University 4.69 -
[20]Type II crude aqueous methanol extracts The same reported above 18.75
Pinobanksin-3-O-acetate Pinocembrin 0.25;0.25
The propolis was from
Guadalcanal Province
(The Solomon Islands) for
BeeVital & Herbal
Apothecary (Withby, UK)
‘Pacific propolis’
Propolis extracted with 95% ethyl alcohol
(EEP). A portion of EEP suspended in
water/ethanol (10/1) was partitioned
between n-hexane (HEX), ethyl acetate (EA),
n-BuOH (BUT) and water (WAT). EA (1-16)
fractions obtained from EA fractionated by
gel fi ltration using Sephadex® LH-20-100
One hundred and twenty clinical
MRSA isolates were collected from
the clinical laboratories of the New
Royal Infirmary (Edinburgh, UK)
EEP: 0.064–0.128; -
HEX: 0.512; -
EA: 0.064–0.128
BUT: 0.128–0.256
WAT: >0.512
EA 9–EA 15: 0.016–0.064
Prenylflavanones: propolin H, propolin G, propolin D,
propolin C [21]
Purchased as
ethanolic extract
Ethanolic extract of propolis (P8904, EEP,
pH 7.3, Sigma, St. Louis, MO, USA) MRSA (ATCC 33591)
1.024; -
Propolis plus mupirocin for
treating nares of the rabbits
infected by MRSA resulted in more
profound reduction in bacterial cell
count and inflammatory response
compared with the rest of the
treatment modalities without
this conjugation
- [22]
Three samples of propolis
were obtained from Croatia:
sample 5587 (Zagreb) and
samples 5582 and
5581 (Imotski)
Hydro-alcoholic extract (80%) of propolis
(EEP), Galangin Ten strains of MRSA
Sample 5587: 1.06; 2.00
Sample 5582: 4.98; 9.37
Sample 5581: 1.19; 2.37
Galangin: 0.16; 0.27
Flavones, flavonols, flavanones, galangin [23]
* MIC: Minimal Inhibitory Concentration; ** MBC: Minimum Bactericidal Concentration; -: not referred by the authors.
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Table 2. Chemical composition of hydro-alcoholic extract of Moroccan propolis.
Aromatic Acids % Phenolic Acid Esters % Flavonoids % Diterpenes % Sugars andSugar Derivatives % Fatty Acids %
Benzoic acid 0.4 Pentenyl p-coumarate 0.7 Pinostrobin chalcone 2.7 Ferruginol 1.2 Monosaccharides 0.4 Hexadecanoic acid -
Hidroxybenzoic acid 0.1 Isopentenyl caffeate 1.8 Pinocembrin chalcone 5.9 Communic acid 2.7 Disaccharides - Octadecanoic acid 1.0
Cinnamic acid 0.3 Pentenyl caffeate 0.9 Pinocembrin 7.4 Totarol 1.1 Glycerol 0.1 Octadecenoic acid 0.5
p-Coumaric acid 0.3 Dimethylallyl caffeate 1.2 Pinobanksin 3.6 Imbricataloic acid 3.2 Inositol Tr Tetracosanoic acid -
Dimethoxycinnamic acid 0.6 Pentenyl ferulate 0.9 Pinobanksin3-O-acetate 3.4 13-epi-Cupressic acid 2.2 Total 0.5 Total 1.5
Ferulic acid 0.4 Benzyl ferulate 1.7 Galangin 5.3 Ferruginolon 1.2
Isoferulic acid 0.4 Benzyl p-coumarate 1.3 Chrysin 3.6 Dehydroabietic acid Tr
Caffeic acid 0.8 Benzyl caffeate 4.7 Total 31.9 Isocupressic acid 8.1
Total 3.3 Caffeic acidphenetyl ester 1.7 Junicedric acid 1.8
Cinnamyl ferulate 0.4 Total 21.5
Cinnamyl caffeate 1.2
Total 16.5
Standard deviation does not succeed 6% for any of the constituents
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2. Results
2.1. Chemical Composition of Propolis Extract
Table 2 depicts the chemical composition of the hydro-alcoholic extract of propolis. Flavonoids
(31.9%), diterpenes (21.5%), and phenolic acid esters (16.5%) were the main groups of compounds found
in this extract. Only four components were present at concentrations higher than 5%: the diterpene
isocupressic acid (8.1%) (1), and the three flavonoids pinocembrin (7.4%) (2), pinocembrin chalcone
(5.9%) (3), and galangin (5.3%) (4). The phenolic acid ester benzyl caffeate (4.7%) (5) was present in the
extract at a concentration very close to 5% (Table 2).
2.2. Characterization of the Nanomaterial
2.2.1. X-ray diffraction (XRD)
Figure 1 displays the XRD patterns of the non-functionalized nanoparticles synthesized by each of
the three methods. The diffraction peaks present in the patterns of all the samples indicate magnetite as
the sole crystalline phase. The smaller width of the peaks in the pattern of Method #2 suggests a larger
size of the nanoparticles in that sample, in agreement with transmission electron microscopy (TEM)
observations. Figure 2 represents the diffractograms of both functionalized and nonfunctionalized
nanoparticles, synthesized by Method #1, where it is evident that the functionalization procedure does
not change the structure and composition of the nanoparticles.
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2.2.2. TEM
This analysis was used to characterize the morphology of the nonfunctionalized nanoparticles
and the results are presented in Figure 3. The images show that the three methods produced
roughly spherical nanoparticles, although those produced by Method #2 are of more regular shape,
with diameters of about 15 nm, while Method #1 originates more angular shaped nanoparticles,
with estimated sizes of 10 nm and Method #3 produces nanoparticles with approximately the same
size but with a more regular spherical shape.
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To further investigate the structure and composition of the as-synthesized MNPs, one sample of
uncoated MNP synthesized by each of the three methods was analyzed by transmission Mössbauer
spectroscopy. The recorded spectra are shown in Figure 5. The room temperature spectra show
the gradual passage from bulk-like to superparamagnetic (SPM) behavior, as the average size of
the particles decrease. The Method #2 spectra displays a single sextet compatible with magnetite,
with board lines indicating that these particles have a multidomain structure, although close to the
single domain size limit. In the Method #3 sample, the central doublet evidences a predominant SPM
size, with some contribution from the non-SPM particles sextet, correlating to a size distribution with
smaller average particle size. Sample from Method #1 exhibits a similar behavior. Thus, it can be stated
from the Mössbauer analysis that Method #2 produces Fe3O4 NPs that have on average a larger size
than those produced by Methods #1 and #3, which is in good agreement with the results of both TEM
and XRD.
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2.2.4. Fourrier Tranform Infrared Spectroscopy (FTIR)
In the FTIR sp ctra of MNPs prepared by Methods #1 and #2 (Figure 6A,B), an intense band near
600 cm−1 and the one centered at 447 cm−1 were observed. A splitting of the former into two bands
(approximat ly 590 and 640 cm−1) was observed. Besides these bands, two other are observed in these
spectra: one centered near 3445 cm−1 and the other around 1640 cm−1.
The FTIR spectrum of MNPs prepared by Method #3 (Figure 6C) does not differ much from the
former, as the only significant absorption band of dehydroascorbic acid, the oxidation product of
ascorbic acid, is from the carbonyl groups, at 1680 cm−1. As a consequence, only a broadening of the
1640 cm−1 band relative to the other NPs samples is observed. Apart from that, two inconspicuous
bands, due to C-H asymmetric and symmetric stretching, may be denoted at nearly 2930 and
2850 cm−1, respectively.
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Upon functionalization with oleic acid, the spectra of all MNPs show changes, indicating the
presence of the fatty acid: the appearance of the C-H asymmetric and symmetric stretching bands,
near 2930 and 2870 cm−1, a broadening of the band at 1640 cm−1, and a new band centered around
1430 cm−1, due to the bending of the methylene groups in OA chain. The broadening of the 1640 cm−1
band is due to a shift in the C=O stretching band, originally near 1710 cm−1, to lower wavenumbers,
upon binding to the surface, that weakens the double bond character of the carbonyl. Nevertheless,
in some samples (MNPs obtained by Methods #1 and #2), a band at 1720 cm−1 was still visible.
After addition of propolis extract, this band remains in the first sample, although less intense,
but disappears or at least fades away in the second one. In MNPs prepared by Method #3 this
band is not present, meaning that the presence of dehydroascorbic acid somehow prevented the
formation of an oleic acid bilayer, in the same manner as the compounds present in the propolis extract,
that seem to decrease the amount of unbound oleic acid.
The effect of the addition of propolis extract on the FTIR spectra is mainly related to the aromatic
compounds, since the aliphatic ones, acids, and esters absorb in the same regions as the compounds
already present. Therefore, only a new band at 2963 cm−1, attributable to the C-H stretching of
unsaturated and aromatic hydrocarbons, as well as a broadening in the band centered near 1430 cm−1,
due to the C=C stretching absorption (in the region 1450–1470 cm−1) are noteworthy in the spectra of
the two first samples. In the last one, the spectra before and after addition of propolis extract seem
practically superimposable, which means that only a very small amount, if any at all, of propolis
compounds were added to the MNPs.
2.3. Impact of the Nanoparticles on Bacterial Adherence
The effect of the nanoparticles on bacterial adherence was evaluated using catheters treated with
different MNPs. The results are illustrated in Figure 7A–C. The percentage of adherence of the cells of
the MSSA strain was not affected by Methods #2 and #3 of nanoparticles production in comparison
to the MRSA strains. However, the adherence of this strain was significantly lower (p < 0.05) by
Method #1, particularly in the presence of propolis (p < 0.001).
The impact of the nanoparticles against the adherence ability of MRSA strains was dependent of
the method of production of the nanoparticles and the strain, being the Method #2 the more efficient in
inhibiting adherence of MRSA strains, particularly MRSA 15, which adherence was significantly lower
(p < 0.001) when the catheters were treated with MNPs functionalized with oleic acid and propolis
extract (50.67% ± 2.90%). The adherence of MRSA 2 was also impaired by the nanoparticles produced
by the Method #2 (p < 0.001). The adherence of the strain MRSA 16 was significantly lower (p < 0.001)
when the catheters were treated with magnetite nanoparticles produced by Method #3 either just with
oleic acid or nanoparticles with oleic acid and propolis extract.
Thus, in order to impair the adherence of MRSA strains, the use MNPs produced by the Method #2
and functionalized with oleic acid or oleic acid plus propolis extract are the more appropriate followed
by the Method #3. To our best knowledge, this is the first study that shows that catheters treated
with magnetite nanoparticles functionalized with oleic acid and Moroccan propolis can impair the
adherence of such problematic pathogenic bacteria, as MRSA strains.
3. Discussion
The presence of diterpenes is common in propolis of Mediterranean origin [24]. This group of
compounds was already reported in some Moroccan propolis [25]. Popova et al. [25] found at least
three main types of propolis of Moroccan origin: flavonoid/phenolic acid esters-type, flavonoid-type,
and diterpene-type. In the present work, flavonoid/diterpene-type, along with a relative high amount
of phenolic acid esters, was found.
The characterization of the nanomaterials was followed by XRD, TEM, Mössbauer spectroscopy,
and FTIR. The diffraction peaks present in the patterns of all the samples indicate magnetite as the
sole crystalline phase [26] (ICDD PDF-2 card #01-071-6337). As reported by Mahdavi et al. [27] for
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functionalized MNPs with oleic acid, XRD data showed negligible effects of this fatty acid on the XRD
spectra data. The morphology and particle size of nanoparticles were similar to those reported by
Anghel et al. [15] for functionalized magnetite (Fe3O4/C18), that is, the same type of functionalization
(oleic acid) done in the present work. In the Mössbauer spectroscopy, and at room temperature, spectra
showed a gradual passage from bulk-like to superparamagnetic (SPM) behavior, as the average size of
the particles decrease, a striking characteristic of the superparamagnetic nature of nanoparticles [28].
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FTIR spectroscopy contributes to provide a fast way of identification of MNPs. This technology is
also useful when there is their functionalizatio , because it allows v rifying the occurrenc of uch
functionalization. In the identification of the nanoparticles, and for the Methods #1 and #2 there
was confirmation of the presence of MNPs due to the intense band near 600 cm−1, attributed to the
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stretching of the Fe-O bond of octahedral positions, and the one centered at 447 cm−1, due to the
stretching of tetrahedral Fe-O [29]. The splitting of the intense band near 600 cm−1 in two bands
(approximately 590 and 640 cm−1) is an effect of the finite size that causes the split of the vibrational
energy levels in the nanoparticles [30]. Two other bands were observed: one centered near 3445 cm−1,
attributed to the O-H stretching both in hydroxyl groups on the MNPs surface and in adsorbed water
molecules, and the other around 1640 cm−1 is attributed to the bending in these molecules [30,31].
Upon functionalization with oleic acid, the spectra of all MNPs show changes, indicating the presence
of the fatty acid, nevertheless, in some samples (MNPs obtained by Methods #1 and #2), a band at
1720 cm−1 was still visible, probably due to the presence of unbound oleic acid molecules, forming
a second layer [30]. The effect of the addition of propolis extract on the FTIR spectra was mainly related
to the aromatic compounds.
The dependence of the method of production of MNPs as well as the strain on the impact of
the adherence ability of microorganisms observed in the present work was also reported by some
authors [16,32], using other strains and methods of production of NPs. The different response of diverse
strains to the same compound or extract is expectable since there are not universal antimicrobials.
However in the presence of functionalized nanoparticles with the same compound or extract, care must
be taken in the production of such NPs, because unexpected activities may occur.
Recently, some works have demonstrated the capacity of propolis extract to prevent the adherence
of several microorganisms (Streptococcus mutans, and several Staphylococcus aureus clinical strains)
on abiotic (smooth glass or microplate) and biotic (HEp-2 (Human Epithelioma) and HeLa (cervical
carcinoma)) surfaces [33–35]. With the exception of Veloz et al. [34], in the remaining works, the authors
did not describe the chemical composition of propolis extracts; only refer the importance of phenol
content on the inhibition of biofilm formation [33], or there is not ever any reference to the composition
of the propolis sample [35].
The anti-MRSA activity of propolis extracts from different origins and consequently with
distinct chemical compositions has been reported, as can be seen in Table 1, nevertheless the
anti-MRSA biofilm formation by propolis is very scarcely reported or even absent, as far as we
know. The capacity for inhibiting the growth of MRSA by propolis extracts has been attributed to
several compounds, including phenolic esters (benzyl caffeate) and flavonoids (pinocembrin, galangin
and their derivatives), also detected in our sample, nevertheless it also presents isocupressic acid,
a diterpene, in relative high amounts; which along with the other phenols may be responsible for the
anti-adherence activity found.
It is noteworthy to refer some discrepancies on the anti-MRSA activities of some components
present in propolis and found in different works developed by diverse authors. As examples:
Boisard et al. [17] found that the flavonoids pinobanksin-3-acetate, pinocembrin, chrysin, and galangin
did not show anti-MRSA activity, in contrast to the prenyl caffeate. Nevertheless, the activities of the
extracts were higher than the isolated compounds, which evidence a synergetic activity among the
compounds present in the extracts. These results disagree with those found by Darwish et al. [20]
and Pepeljnjak and Kosalec [23]. These authors reported higher activity of pinobanksin-3-acetate,
pinocembrin and galangin than crude extracts.
Functionalized Fe3O4/C18 nanoparticles without propolis extract present ability for inhibiting the
adherence of MRSA strains, as already reported by Anghel et al. [15], nevertheless always inferior when
compared to those samples also functionalized with propolis extract, which reveals the importance of
this extract on the activity.
4. Materials and Methods
4.1. Chemicals and Reagents
Hydrochloric acid (HCl) and L-(+)-Ascorbic acid were purchased from Merck (Darmstadt,
Germany). Na2CO3 and Na2SO3 were purchased from Riedel de Haen (Seelze, Germany). Chloroform
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(CHCl3) was purchased from LAB-SCAN (Dublin, Ireland). Oleic acid and Iron(II) sulfate heptahydrate
(FeSO4·7H2O) were purchased from Sigma Aldrich (Steinheim, Germany). Iron(III) chloride anhydrous
was purchased from Fluka Chemicals (Buchs, Switzerland). NaOH was from Pronalab (Madalena,
Portugal). Ethanol was from Panreac Quimica (Barcelona, Spain). The medium brain-heart infusion
(BHI) and Bacteriological agar type E were purchased from Biokar Diagnostics (Beauvais, France).
4.2. Propolis Extract
One gram of propolis from Morocco (region of Fez-Boulmane) was chopped into small pieces
and extracted by maceration using 30 mL of 70% ethanol and maintained for one week at 37 ◦C under
agitation (200 rpm). The resulting solution was filtered under vacuum. A clear solution, without
further purification, was used for successive analyses.
4.3. GC-MS Analysis of Propolis Extract
The analysis was performed with a Hewlett-Packard gas chromatograph 5890 series II Plus
linked to a Hewlett-Packard 5972 mass spectrometer (Hewlett-Packard, Wilmington, DE, USA) system
equipped with a 30 m long, 0.25 mm i.d., and 0.5 µm film thickness HP5-MS capillary column. The work
conditions were the same as previously reported [25]. Semi-quantification was carried out by internal
normalization with the area of each compound. The addition of individual areas of the compounds
corresponds to 100% area. Compound identification was performed using commercial libraries and
comparison of mass spectra and retention times of reference compounds.
4.4. Preparation of Magnetite Nanoparticles
Magnetite nanoparticles were synthesized by three different methods.
4.4.1. Method #1
The alkaline co-precipitation of iron salts in aqueous solutions, as described by Kang et al. [36],
with some modifications, was as follows: 0.43 mL of HCl 12 M was diluted with 12.5 mL of distilled
water, and then 2.6 g of FeCl3 and 2.4 g of FeSO4·7H2O (2:1 molar ratio) were both added under
continuous magnetic stirring. The resulting solution was poured into 125 mL of NaOH (1.5 M) under
vigorous stirring, which was maintained for 30 min. The last step generated an instant black precipitate.
The magnetism was checked with a NdFeB permanent magnet. The precipitate was attracted by the
magnetic field, and the supernatant was removed by decantation. The recovered magnetite was
washed with distilled water for three times and then twice with ethanol. The product was air-dried
overnight and grinded into powder.
4.4.2. Method #2
The co-precipitation, according to the procedure of Qu et al. [37] slightly modified, was as follows:
30 mL of a 2 M FeCl3 stock solution, prepared by dissolving the necessary amount of iron salt in
2 M HCl, were diluted with an equal volume of deionized water. Afterwards, 20 mL of a 1 M Na2SO3
solution were added under stirring. Just after the mixing of Fe3+ and SO32−, the color of the solution
altered from light yellow to red, indicating the formation of a complex ion. Meanwhile, an ammonia
solution was prepared by the dilution of 50.8 mL of concentrated ammonia to a final volume of 800 mL.
The former solution was quickly poured into the diluted ammonia solution, under vigorous stirring,
as soon as its color changed back from red to yellow again, as the complex decomposed to Fe2+ and
SO42−. A black precipitate formed immediately, but stirring was continued for 30 min. A permanent
magnet was applied to the beaker containing the suspension, and a black powder could be seen to
quickly settle on the bottom. The supernatant was discarded and fresh water was added to the beaker.
After decantation, the powder was washed one time with an acidic solution (pH 3–4), then with
distilled water until neutral pH, once with ethanol, and finally left to air dry overnight.
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4.4.3. Method #3
Water-soluble magnetite nanoparticles were obtained by a hydrothermal method, according
to Xuan et al. [38], using a ferric salt as single iron precursor, and ascorbic acid as reducing agent.
The so synthesized super paramagnetic Fe3O4 nanocrystals are capped with dehydroascorbic acid
(the oxidized form of ascorbic acid). In a typical experiment, 0.33 g of FeCl3 were dissolved in 25 mL
of H2O, under continuous stirring. Then, 10 mL of 0.6 M Na2CO3 (0.6 M) were added, drop by
drop and, 10 min later, 0.12 g ascorbic acid were also added. After being stirred for another 15 min,
the solution was transferred to a 40 mL Teflon sealed autoclave. The autoclave was kept at 160 ◦C
for 3 h and then let cool down to room temperature. The final product was separated from the
reaction medium by using a NdFeB permanent magnet. A rinsing process including three cycles
of decantation/washing/decantation in deionized water and in alcohol was performed before air
drying overnight.
4.5. Preparation of Functionalized Magnetite Nanoparticles
Each magnetite type was functionalized with 6 mL of oleic acid (OA), the mixture being heated
up to 80 ◦C on a water bath, under intense stirring for 60 min. Excess oleic acid was phase separated
by dropwise addition of 4 mL of water, followed by OA-coated magnetite washing twice with ethanol
and kept to dry overnight [39].
4.6. Synthesis of A Hybrid Core/Shell/Coated Shell Nanomaterial
Functionalized magnetite was added into 10 mL of CHCl3 (0.33% w/v) and was sonicated for
30 min. One mL of propolis sample at the MIC value (0.36 mg/mL) was added into the same volume
of the magnetite suspension.
4.7. Characterization of the Nanomaterial
Characterization of the nanomaterial was carried out by X-ray powder diffraction (XRD),
transmission electron microscopy (TEM) (Hitachi High-Technologies Corporation, Tokyo, Japan),
57Fe Mossbauer spectroscopy, and Fourier Transform Infrared (FTIR) spectroscopy (Bruker Tensor 27,
Billerica, MA, USA).
4.7.1. XRD
The structure type of all the samples was checked by powder X-ray diffraction on a PANalytical
X’Pert Pro diffractometer (PANalitycal, Almelo, The Netherlands) using Cu Ka radiation filtered by Ni
and an X’Celerator detector. The equipment was operated at 45 kV and 30 mA and the patterns were
recorded in the range 20–80◦ 2θ, with a step size of 0.05◦ and 1500 seconds per step and compared
with the ICDD PDF-2 database.
4.7.2. TEM
Samples were prepared by drop drying a diluted colloidal solution of NPs in ethanol onto
200 mesh Formvar-coated copper grids. Samples were observed using a Hitachi 8100 (Hitachi
High-Technologies Corporation), 200 kV, LaB6 filament analytical transmission electron microscope.
4.7.3. Mossbauer Spectroscopy
57Fe Mossbauer spectroscopy was performed at room temperature on a Wissel constant
acceleration transmission mode spectrometer (Wissenschaftliche Elektronik (WissEl) GmbH, Starnberg,
Germany), using a proportional counter as detector and a 57Co/Rh source. The resulting spectra were
calibrated with an α-Fe foil and WMOSS software [40] was used for the quantitative evaluation of the
spectral parameters (least-squares fitting to Lorentzian peaks). All isomeric shifts are reported relative
to the centroid of the α-Fe spectrum.
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4.7.4. FTIR
Infrared spectra were recorded in the wave numbers range 4000–400 cm−1, in a Bruker Tensor 27
Fourier-transform infrared (FT-IR) spectrophotometer (Bruker Tensor 27, Billerica, MA, USA), using
KBr wafers.
4.8. Impact of the Nanoparticles on Bacterial Adherence
Catheter pieces treated with functionalized magnetite and propolis were filled with 100 µL
of an overnight bacterial culture MSSA ATCC 6538, MRSA 2, MRSA 15 and MRSA 16 (Table 3).
The bacterial strains were cultivated in Brain Heart Infusion (BHI). For solid media, agar (VWR) was
added at 1.5%, w/v. Bacteria were maintained in BHI with 25% (v/v) glycerol at −80 ◦C and, when
necessary were recovered in BHI. Prior to use, bacteria were transferred to fresh BHI agar plates and
incubated at 37 ◦C.
Table 3. Staphylococcus aureus strains.
Bacteria Origin Source
Staphylococcus aureus ATCC 6538 (MSSA ATCC 6538) Wound American Type Culture Collection
Staphylococcus aureus methicillin-resistant 2 (MRSA 2) Clinical UAlg, CBMR. Portugal
Staphylococcus aureus methicillin-resistant 15 (MRSA 15) Clinical UAlg, CBMR. Portugal
Staphylococcus aureus methicillin-resistant 16 (MRSA 16) Clinical UAlg, CBMR. Portugal
The previously obtained suspension of the nanomaterial was used to fabricate a modified surface
in a prosthetic device. This was achieved by submerging the catheter pieces into the fluid in order
to create a coating film. The catheter pieces were then dried at room temperature. This process of
submerging and drying was repeated for five times of 10 s each, and the catheter pieces were sterilized
by ultraviolet radiation for 20 min.
Catheter pieces treated with functionalized magnetite were filled with 100 µL of an overnight
bacterial culture and left to adhere for 30 min at room temperature in a flow cabinet (Faster BH-EN
2005, Milan, Italy). Following the catheter pieces were transferred to Falcon tubes with 10 mL of Brain
Heart Infusion (BHI) (Oxoid). Each tube was sonicated in a bath sonicator (J.P.SELECTA, Barcelona,
Spain) for 5 min, and the catheter was immediately removed. The bacterial suspension was serially
diluted using phosphate buffer saline (PBS) and the viability was determined according to the Miles
and Misra technique [41]. Catheters treated with non-functionalized magnetite and catheters not
treated with magnetite were used as control [12].
4.9. Statistical Analysis
For the statistical interpretation GraphPad Prism statistical software was used, version 5.03
(GraphPad Software, La Jolla, CA, USA). The average of six independent experiments were analyzed
and compared with one-way ANOVA using Tukey’s Multiple Comparison Test of each group, followed
by two-way ANOVA test for revealing significant differences among the analyzed group. Significant
differences were indicated by p values less than 0.05.
5. Conclusions
The capacity of functionalized MNPs for preventing the adherence of S. aureus to catheters was
dependent on two factors: the bacterial strain and the mode of production of the NPs. The MSSA
ATCC 6538 strain was less affected by the presence of the functionalized MNPs, independently on
the type of production, in contrast to the MRSA strains. For MRSA strains, the MNPs produced using
Fe3+ and Na2SO3 solution and functionalized with oleic acid and propolis extract was most effective
in the prevention of adherence of almost all MRSA strains on catheters. The hybrid MNPs produced
by a hydrothermal method also had an impact in the impaired of the adherence of the strain MRSA16
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on catheters. The anti-MRSA activities reported for phenolic esters (benzyl caffeate) and flavonoids
(pinocembrin, galangin and their derivatives), constituents of several types of propolis and also present
in our sample can be the reason, along with MNPs, for the observed activities. However, the main
compound, isocupressic acid, may also have a role in the anti-adherence activities detected, although
to the best of our knowledge no reference has been found upon its anti-MRSA potential. In addition,
for MRSA16, the impairment of its adherence on catheters may only be attributed to the hybrid MNPs
with oleic acid, since very small amount, if any at all, of propolis compounds were added to the MNPs,
according to the FTIR spectra.
Nanotechnology may provide a new approach to prevent or disrupt the formation of biofilms
on medical devices. The association of natural products, such as propolis, with nanotechnology may
constitute an alternative to combat the formation of those biofilm in catheters by MRSA strains.
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